Paxil Unsafe for Teenagers
In 2001, pharmaceutical company GlaxoSmithKline pushed a study that concluded its antidepressant drug Paxil was safe and effective for teens. This week, the British Medical Journal concluded that, based upon the same data, the opposite is true – that Paxil is neither safe nor effective in adolescents with depression. In an article entitled “No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility,” the associate editor of the BMJ blasts the original study and raises serious questions about the process by which the original study was published. It is so very sad to think that thousands of young people may have been harmed by reliance upon a flawed and perhaps dishonest study pushed by a desire for sales and profit.
Source:
http://www.bmj.com/content/351/bmj.h4629